Implementation of Momentum SpineTM: a New 3D Imaging Software for Idiopathic Scoliosis
1 other identifier
observational
142
0 countries
N/A
Brief Summary
Brief Summary The goal of this clinical trial is to evaluate the implementation of Momentum Spine™, a new 3D imaging software designed to improve the monitoring and management of idiopathic scoliosis in children aged 8-14 years. Idiopathic scoliosis affects 1-3% of the pediatric population and is currently monitored through hospital visits with radiographic imaging every 4-6 months, which exposes patients to cumulative radiation over time. This study explores whether Momentum Spine™ can provide a safer, more accessible alternative by enabling at-home monitoring using clinical photographs taken on smartphones. The primary questions this study seeks to answer are: Can Momentum Spine™ accurately predict scoliosis progression, including Cobb angle changes, compared to standard radiographic assessments? Can the use of Momentum Spine™ reduce the number of X-rays required and improve the timing of clinical follow-ups? Does the use of Momentum Spine™ affect patient satisfaction, healthcare utilization, and overall quality of life? This study is a prospective, two-arm randomized controlled trial conducted at CHU Sainte-Justine. Participants will be divided into two groups: the control group will receive standard care, which involves regular clinical visits and radiographic evaluations; the intervention group will use Momentum Spine™ at home, alongside standard care. Intervention Details Participants in the intervention group will: Use the Momentum Spine™ application to capture 3D images of their torso at home every two months. These images will be processed by Momentum Spine™ algorithms to assess curve progression. Participants will receive notifications and guidance on performing scans at home, supported by the study team to ensure accuracy. The primary outcomes include clinical measures such as changes in Cobb angle at 1 and 2 years, curve progression of more than 5 degrees, whether the main curve reaches 45 degrees, and the need for surgical referral. Secondary outcomes focus on the accuracy, sensitivity, and specificity of Momentum Spine™, as well as patient-reported measures such as health-related quality of life and satisfaction with care, users' acceptability of the software, healthcare services utilization and pathway costs. This study also aims to address key challenges in scoliosis care, including reducing radiation exposure, improving follow-up timing to align with growth spurts, and providing equitable access to care for families who may live far from specialty clinics. By validating the performance of Momentum Spine™, this trial has the potential to transform scoliosis management, ensuring safer and more effective care pathways.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2025
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2025
CompletedFirst Posted
Study publicly available on registry
January 16, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
January 16, 2025
December 1, 2024
2.8 years
January 10, 2025
January 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cobb angle
The primary outcomes will be clinical progression including: Cobb angle of the main curve at 1 and 2 years of follow up, progression of Cobb angle of more than 5 degrees, whether the main curve reaches 45 degrees during follow-up or whether the patient is referred to surgery.
1 and 2 years
Secondary Outcomes (1)
Performance of the software
All the time
Study Arms (2)
Control arm
Standard care will be provided to the control arm group. This includes standard 4 to 6-month consultatiosn with the orthopedic surgeons, follow-up standard x-ray (lateral and posterioanterior) examinations, measures of the angle of trunk rotation and Cobb angles, topographic scans performed by the study coordinator using the Momentum Health TM application, at each clincal visits.
Intervention arm
In addition to the standard care, patients randomized to the Intervention arm of the trial will perform Momentum SpineTM assessment from home at 2-month intervals during the 24-month study follow-up. If a progression is detected using Momentum SpineTM, the participant will be promptly invited to acquire a second set of scans for confirmation. In case of confirmation of the progression using the images from the repeated scans, the scan results will be sent to their local orthopedic surgeon.
Interventions
Patients randomized to the Intervention arm of the trial will additionally use Momentum SpineTM assessment from home at 2-month intervals. If a progression is detected using Momentum SpineTM the participant will be promptly invited to acquire a second set of scans for confirmation. In case of confirmation of the progression using the images from the repeated scans, the scan results will be sent to their local orthopedic surgeon.
Eligibility Criteria
Children with idiopathic scoliosis diagnosis.
You may qualify if:
- Children aged between 8 and 14 with a confirmed radiographic diagnosis of Idiopathic Scoliosis who have not undergone spinal nor thoracic surgery.
You may not qualify if:
- Patients who may be pregnant. Patients with the existence of a second deformity, or any other neuromuscular condition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Justine's Hospitallead
- Mitacscollaborator
- Ministère de l'économie, de l'innovation et de l'énergie du Québeccollaborator
- Momentum Health Inc.collaborator
- Université de Sherbrookecollaborator
- Université Clermont-Auvergne, Francecollaborator
Related Publications (3)
Girdler S, Cho B, Mikhail CM, Cheung ZB, Maza N, Kang-Wook Cho S. Emerging Techniques in Diagnostic Imaging for Idiopathic Scoliosis in Children and Adolescents: A Review of the Literature. World Neurosurg. 2020 Apr;136:128-135. doi: 10.1016/j.wneu.2020.01.043. Epub 2020 Jan 16.
PMID: 31954891BACKGROUNDElwyn G, Edwards A, Wensing M, Grol R. Shared Decision Making Measurement using the OPTION instrument. 2005. Accessible from
BACKGROUNDWeinstein SL, Dolan LA, Cheng JC, Danielsson A, Morcuende JA. Adolescent idiopathic scoliosis. Lancet. 2008 May 3;371(9623):1527-37. doi: 10.1016/S0140-6736(08)60658-3.
PMID: 18456103BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor-Researcher
Study Record Dates
First Submitted
January 10, 2025
First Posted
January 16, 2025
Study Start
March 1, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2028
Last Updated
January 16, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share